Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-03-05 16:23 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-8,484 vol |
89,295 | |
Filed 2024-03-05 16:23 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+19,816 vol |
97,779 | |
Filed 2024-03-05 16:22 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-19,816 vol |
254,971 | |
Filed 2024-03-05 16:21 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-3,269 vol |
77,963 | |
Filed 2024-03-05 16:20 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,634 vol |
81,232 | |
Filed 2024-03-05 16:19 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,634 vol |
274,787 | |
Filed 2024-03-05 16:18 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-451 vol |
73,598 | |
Filed 2024-03-05 16:17 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,053 vol |
74,049 | |
Filed 2024-03-05 16:17 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,053 vol |
282,421 | |
Filed 2024-03-05 16:16 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-406 vol |
72,996 | |
Filed 2024-03-05 16:15 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+948 vol |
73,402 | |
Filed 2024-03-05 16:14 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-948 vol |
283,474 | |
Filed 2024-03-05 16:12 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-16,973 vol |
89,108 | |
Filed 2024-03-05 16:11 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+31,706 vol |
106,081 | |
Filed 2024-03-05 16:11 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-31,706 vol |
417,110 | |
Filed 2024-03-05 16:10 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-5,994 vol |
74,375 | |
Filed 2024-03-05 16:09 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+11,197 vol |
80,369 | |
Filed 2024-03-05 16:08 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,197 vol |
448,816 | |
Filed 2024-03-05 16:07 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-511 vol |
69,172 | |
Filed 2024-03-05 16:07 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+953 vol |
69,683 | |
Filed 2024-03-05 16:06 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-953 vol |
460,013 | |
Filed 2024-03-05 16:05 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-765 vol |
68,730 | |
Filed 2024-03-05 16:03 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,429 vol |
69,495 | |
Filed 2024-03-05 16:03 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,429 vol |
460,966 | |
Filed 2024-03-05 15:57 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-3,188 vol |
16,579 | |
Filed 2024-03-05 15:57 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,422 vol |
19,767 | |
Filed 2024-03-05 15:56 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,422 vol |
90,485 | |
Filed 2024-03-05 15:53 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-87,803 vol |
378,181 | |
Filed 2024-03-05 15:52 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+174,385 vol |
465,984 | |
Filed 2024-03-05 15:51 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-174,385 vol |
923,642 | |
Filed 2024-03-05 15:50 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-23,871 vol |
291,599 | |
Filed 2024-03-05 15:49 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,897 vol |
315,470 | |
Filed 2024-03-05 15:48 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,897 vol |
1,098,027 | |
Filed 2024-03-05 15:47 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-2,413 vol |
264,573 | |
Filed 2024-03-05 15:46 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,944 vol |
266,986 | |
Filed 2024-03-05 15:45 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,944 vol |
1,148,924 | |
Filed 2024-03-05 15:44 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-2,895 vol |
262,042 | |
Filed 2024-03-05 15:44 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,932 vol |
264,937 | |
Filed 2024-03-05 15:42 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,932 vol |
1,153,868 | |
Filed 2024-03-04 18:27 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+39,126 vol |
98,907 | |
Filed 2024-03-04 18:25 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+73,768 vol |
284,422 | |
Filed 2024-03-04 18:22 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+147,536 vol |
462,395 | |
Filed 2024-03-04 18:18 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+519,328 vol |
1,159,800 | |
Filed 2024-01-02 17:28 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,245
+3,896 vol $8.02 each |
222,334 | |
Filed 2024-01-02 17:24 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,122
+4,130 vol $8.02 each |
104,634 | |
Filed 2024-01-02 17:22 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
63,130 | |
Filed 2024-01-02 17:18 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+7,793 vol $8.02 each |
202,419 | |
Filed 2024-01-02 17:14 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,873
+857 vol $8.02 each |
169,259 | |
Filed 2023-04-05 12:36 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
||
Filed 2023-12-05 16:46 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-1,691 vol |
72,454 | |
Filed 2023-12-05 16:45 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,158 vol |
74,145 | |
Filed 2023-12-05 16:45 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
210,654 | |
Filed 2023-12-05 16:28 Tx date 2023-12-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-220 vol |
68,066 | |
Filed 2023-12-05 16:27 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-1,691 vol |
68,286 | |
Filed 2023-12-05 16:26 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,158 vol |
69,977 | |
Filed 2023-12-05 16:26 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
314,859 | |
Filed 2023-11-07 17:41 Tx date 2023-11-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-327.23
-43 vol $7.61 each |
66,819 | |
Filed 2023-11-07 17:40 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,528.38
-334 vol $7.57 each |
66,862 | |
Filed 2023-11-07 17:39 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,716
+623 vol $7.57 each |
67,196 | |
Filed 2023-11-07 17:38 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-4,716.11
-623 vol $7.57 each |
318,017 | |
Filed 2023-10-03 11:45 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,496
+7,603 vol $8.22 each |
194,626 | |
Filed 2023-10-03 11:42 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,118
+4,029 vol $8.22 each |
100,504 | |
Filed 2023-10-03 11:38 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,871
+836 vol $8.22 each |
168,402 | |
Filed 2023-10-03 11:30 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,244
+3,801 vol $8.22 each |
218,438 | |
Filed 2023-09-07 10:50 Tx date 2023-09-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,351.80
-6,685 vol $8.28 each |
66,573 | |
Filed 2023-09-07 10:48 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-428,663.95
-51,337 vol $8.35 each |
73,258 | |
Filed 2023-09-07 10:47 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$800,781
+95,902 vol $8.35 each |
124,595 | |
Filed 2023-09-07 10:47 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-95,902 vol |
318,640 | |
Filed 2023-09-07 10:44 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-233,758.25
-27,995 vol $8.35 each |
70,987 | |
Filed 2023-09-07 10:43 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$545,981
+65,387 vol $8.35 each |
98,982 | |
Filed 2023-09-07 10:41 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-65,387 vol |
213,812 | |
Filed 2023-09-07 10:36 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-366,965.80
-43,948 vol $8.35 each |
104,578 | |
Filed 2023-09-07 10:33 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,043,441
+124,963 vol $8.35 each |
148,526 | |
Filed 2023-09-07 10:29 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-124,963 vol |
460,355 | |
Filed 2023-09-07 10:25 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-33,249.70
-3,982 vol $8.35 each |
11,345 | |
Filed 2023-09-07 10:24 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$97,060
+11,624 vol $8.35 each |
15,327 | |
Filed 2023-09-07 10:23 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,624 vol |
59,781 | |
Filed 2023-09-05 18:21 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-119,379.06
-14,111 vol $8.46 each |
259,005 | |
Filed 2023-09-05 18:20 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$254,536
+30,087 vol $8.46 each |
273,116 | |
Filed 2023-09-05 18:20 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-30,087 vol |
640,472 | |
Filed 2023-07-05 15:26 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$12,776
+1,597 vol $8.00 each |
94,147 | |
Filed 2023-07-04 17:03 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
$-31,529
-3,845 vol $8.20 each |
79,422 | |
Filed 2023-07-04 17:02 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$92,036
+11,224 vol $8.20 each |
83,267 | |
Filed 2023-07-04 17:02 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,224 vol |
38,272 | |
Filed 2023-07-04 16:56 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,872
+859 vol $8.00 each |
167,566 | |
Filed 2023-07-04 16:54 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,120
+4,140 vol $8.00 each |
96,475 | |
Filed 2023-07-04 16:52 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,248
+3,906 vol $8.00 each |
214,637 | |
Filed 2023-07-04 16:49 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,496
+7,812 vol $8.00 each |
187,023 | |
Filed 2023-06-21 16:07 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,274.60
-1,929 vol $7.40 each |
3,703 | |
Filed 2023-06-21 16:06 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$41,676
+5,632 vol $7.40 each |
5,632 | |
Filed 2023-06-21 16:04 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-06-21 16:04 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,632 vol |
71,405 | |
Filed 2023-05-23 13:00 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
166,707 | |
Filed 2023-05-23 12:58 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
150,016 | |
Filed 2023-05-23 12:57 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
210,731 | |
Filed 2023-05-23 12:55 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Power, Robert Noel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
158,415 | |
Filed 2023-05-23 12:53 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
179,211 | |
Filed 2023-05-23 12:51 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
65,909 | |
Filed 2023-05-23 12:49 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
88,673 | |
Filed 2023-05-23 12:47 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Kavanagh, Sarah Baldwin
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
146,652 | |
Filed 2023-05-23 12:44 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
92,335 | |
Filed 2023-04-28 16:08 Tx date 2023-04-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Bailey, Ambrose Robert Douglas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-04-05 12:42 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,868
+848 vol $8.10 each |
137,502 | |
Filed 2023-04-05 12:40 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
55 - Expiration of warrants
|
$33,291
+4,110 vol $8.10 each |
181,526 | |
Filed 2023-04-05 12:38 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+7,716 vol $8.10 each |
150,006 | |
Filed 2023-04-05 12:36 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
63,130 | |
Filed 2023-04-05 12:33 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,500
+3,642 vol $8.10 each |
92,550 | |
Filed 2023-03-06 18:55 Tx date 2023-03-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,539.15
-495 vol $9.17 each |
28,693 | |
Filed 2023-03-06 18:54 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,285.20
-780 vol $9.34 each |
29,188 | |
Filed 2023-03-06 18:52 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,680.76
-511 vol $9.16 each |
29,968 | |
Filed 2023-03-06 18:51 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,729
+953 vol $9.16 each |
30,479 | |
Filed 2023-03-06 18:51 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,007.40
-765 vol $9.16 each |
29,526 | |
Filed 2023-03-06 18:50 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,089
+1,429 vol $9.16 each |
30,291 | |
Filed 2023-03-06 18:49 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-8,124.92
-887 vol $9.16 each |
28,862 | |
Filed 2023-03-06 18:48 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,178
+1,657 vol $9.16 each |
29,749 | |
Filed 2023-03-06 18:47 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,994.92
-1,637 vol $9.16 each |
28,092 | |
Filed 2023-03-06 18:46 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$28,286
+3,058 vol $9.25 each |
29,729 | |
Filed 2023-03-06 18:45 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-953 vol |
414,542 | |
Filed 2023-03-06 18:45 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,429 vol |
415,495 | |
Filed 2023-03-06 18:44 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-1,657 vol |
0 | |
Filed 2023-03-06 18:43 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-3,058 vol |
1,657 | |
Filed 2023-03-06 18:41 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-55,444.50
-5,994 vol $9.25 each |
26,671 | |
Filed 2023-03-06 18:41 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$103,572
+11,197 vol $9.25 each |
32,665 | |
Filed 2023-03-06 18:40 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,197 vol |
416,924 | |
Filed 2023-03-06 18:38 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$879,850
+95,119 vol $9.25 each |
428,121 | |
Filed 2023-03-06 18:37 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+82,117 vol |
265,698 | |
Filed 2023-03-06 18:34 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,445.32
-1,577 vol $9.16 each |
243,029 | |
Filed 2023-03-06 18:33 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-17,339.88
-1,893 vol $9.16 each |
244,606 | |
Filed 2023-03-06 18:32 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-21,590.12
-2,357 vol $9.16 each |
246,499 | |
Filed 2023-03-06 18:31 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,827.68
-4,348 vol $9.16 each |
248,856 | |
Filed 2023-03-06 18:30 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$117,419
+12,694 vol $9.25 each |
253,204 | |
Filed 2023-03-06 18:29 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,943 vol |
670,559 | |
Filed 2023-03-06 18:29 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,932 vol |
675,502 | |
Filed 2023-03-06 18:28 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-6,881 vol |
121,770 | |
Filed 2023-03-06 18:27 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-12,694 vol |
128,651 | |
Filed 2023-03-06 18:25 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-161,246
-17,432 vol $9.25 each |
240,510 | |
Filed 2023-03-06 18:23 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$470,788
+50,896 vol $9.25 each |
257,942 | |
Filed 2023-03-06 18:23 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,896 vol |
681,434 | |
Filed 2023-03-06 18:21 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$4,839,183
+523,155 vol $9.25 each |
732,330 | |
Filed 2023-03-06 18:18 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,645
+1,053 vol $9.16 each |
33,595 | |
Filed 2023-03-06 18:17 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,683
+948 vol $9.16 each |
32,542 | |
Filed 2023-03-06 18:13 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,131.16
-451 vol $9.16 each |
31,594 | |
Filed 2023-03-06 18:13 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-3,718.96
-406 vol $9.16 each |
32,045 | |
Filed 2023-03-06 18:12 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,053 vol |
279,199 | |
Filed 2023-03-06 18:11 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-948 vol |
280,252 | |
Filed 2023-03-06 18:10 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,314.36
-471 vol $9.16 each |
32,451 | |
Filed 2023-03-06 18:09 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,950.88
-868 vol $9.16 each |
32,922 | |
Filed 2023-03-06 18:08 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,066
+1,099 vol $9.16 each |
33,790 | |
Filed 2023-03-06 18:08 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,567
+2,027 vol $9.16 each |
32,691 | |
Filed 2023-03-06 18:07 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-1,099 vol |
0 | |
Filed 2023-03-06 18:06 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,027 vol |
1,099 | |
Filed 2023-03-06 17:55 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-37,009.25
-4,001 vol $9.25 each |
23,563 | |
Filed 2023-03-06 17:54 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$134,957
+14,590 vol $9.25 each |
27,564 | |
Filed 2023-03-06 17:54 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-14,590 vol |
585,318 | |
Filed 2023-03-06 17:53 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$1,319,771
+142,678 vol $9.25 each |
599,908 | |
Filed 2023-03-06 17:51 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+123,177 vol |
512,907 | |
Filed 2023-03-06 17:46 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+21,812 vol |
21,812 | |
Filed 2023-03-06 17:45 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-03-06 17:44 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$233,710
+25,266 vol $9.25 each |
77,037 | |
Filed 2023-03-06 17:40 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-30,238.25
-3,269 vol $9.25 each |
30,664 | |
Filed 2023-03-06 17:39 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$70,614
+7,634 vol $9.25 each |
33,933 | |
Filed 2023-03-06 17:39 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,634 vol |
281,200 | |
Filed 2023-03-06 17:37 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$549,903
+59,449 vol $9.25 each |
288,834 | |
Filed 2023-03-06 17:36 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+51,324 vol |
176,998 | |
Filed 2023-03-06 17:34 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,674 | ||
Filed 2023-03-01 18:47 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-3,751.44
-392 vol $9.57 each |
26,299 | |
Filed 2023-03-01 18:46 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,756
+915 vol $9.57 each |
26,691 | |
Filed 2023-03-01 18:46 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-915 vol |
229,385 | |
Filed 2023-03-01 18:45 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,196.64
-752 vol $9.57 each |
25,776 | |
Filed 2023-03-01 18:44 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,804
+1,756 vol $9.57 each |
26,528 | |
Filed 2023-03-01 18:43 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-1,756 vol |
3,126 | |
Filed 2023-03-01 18:43 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
4,882 | ||
Filed 2023-03-01 18:34 Tx date 2023-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,721.44
-292 vol $9.32 each |
21,468 | |
Filed 2023-03-01 18:33 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,349.76
-768 vol $9.57 each |
21,760 | |
Filed 2023-03-01 18:32 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,723
+1,434 vol $9.57 each |
22,528 | |
Filed 2023-03-01 18:32 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,434 vol |
333,002 | |
Filed 2023-03-01 18:30 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,106.18
-1,474 vol $9.57 each |
21,094 | |
Filed 2023-03-01 18:30 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$26,336
+2,752 vol $9.57 each |
22,568 | |
Filed 2023-03-01 18:29 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,752 vol |
4,715 | |
Filed 2023-03-01 18:24 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-40,749.06
-4,258 vol $9.57 each |
207,046 | |
Filed 2023-03-01 18:23 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$119,117
+12,447 vol $9.57 each |
211,304 | |
Filed 2023-03-01 18:22 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-12,447 vol |
141,345 | |
Filed 2023-03-01 18:21 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-19,800.33
-2,069 vol $9.57 each |
198,857 | |
Filed 2023-03-01 18:21 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$62,042
+6,483 vol $9.57 each |
200,926 | |
Filed 2023-03-01 18:20 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
209,175 | |
Filed 2023-01-04 17:47 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,626.80
-6,310 vol $6.28 each |
12,974 | |
Filed 2023-01-04 17:46 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$121,103
+19,284 vol $6.28 each |
19,284 | |
Filed 2023-01-04 17:45 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-01-04 17:42 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-19,284 vol |
457,230 | |
Filed 2023-01-04 17:07 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,870
+1,094 vol $6.28 each |
136,654 | |
Filed 2023-01-04 17:05 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,370
+5,473 vol $6.28 each |
177,416 | |
Filed 2023-01-04 17:03 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,498
+9,952 vol $6.28 each |
142,290 | |
Filed 2023-01-04 17:01 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,818
+4,589 vol $6.28 each |
59,468 | |
Filed 2023-01-04 16:59 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,818
+4,589 vol $6.28 each |
59,446 | |
Filed 2023-01-04 16:57 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$32,568
+5,186 vol $6.28 each |
88,908 | |
Filed 2022-12-02 12:42 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-13,020.70
-1,691 vol $7.70 each |
19,816 | |
Filed 2022-12-02 12:39 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-10,418.10
-1,353 vol $7.70 each |
24,772 | |
Filed 2022-12-02 12:38 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$24,316
+3,158 vol $7.70 each |
26,125 | |
Filed 2022-12-02 12:37 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,967 | ||
Filed 2022-12-02 12:34 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
230,300 | |
Filed 2022-12-02 12:31 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-11,295.90
-1,467 vol $7.70 each |
||
Filed 2022-12-02 12:30 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$24,316
+3,158 vol $7.70 each |
21,507 | |
Filed 2022-12-02 12:30 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
334,436 | |
Filed 2022-11-07 15:35 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,154.30
-334 vol $6.45 each |
18,349 | |
Filed 2022-11-07 15:34 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,018
+623 vol $6.45 each |
18,683 | |
Filed 2022-11-07 15:33 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-623 vol |
337,594 | |
Filed 2022-10-04 16:41 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,869
+997 vol $6.89 each |
135,560 | |
Filed 2022-10-04 16:39 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,374
+4,989 vol $6.89 each |
171,943 | |
Filed 2022-10-04 16:36 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+9,071 vol $6.89 each |
132,338 | |
Filed 2022-10-04 16:34 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+4,444 vol $6.89 each |
54,879 | |
Filed 2022-10-04 16:31 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+4,444 vol $6.89 each |
54,857 | |
Filed 2022-10-04 16:28 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,374
+4,989 vol $6.89 each |
83,722 | |
Filed 2022-09-15 15:30 Tx date 2022-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-762,430
-100,000 vol $7.62 each |
934,594 | |
Filed 2022-09-15 15:29 Tx date 2022-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-389,000
-50,000 vol $7.78 each |
1,034,594 | |
Filed 2022-09-15 15:26 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-26,665.28
-3,623 vol $7.36 each |
1,084,594 | |
Filed 2022-09-15 15:26 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$52,130
+7,083 vol $7.36 each |
1,088,217 | |
Filed 2022-09-15 15:25 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,083 vol |
76,448 | |
Filed 2022-09-09 12:01 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+196,163 vol |
233,458 | |
Filed 2022-09-09 12:00 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
37,295 | ||
Filed 2022-09-08 11:09 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,873 vol |
51,771 | |
Filed 2022-09-08 11:07 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+287,707 vol |
338,217 | |
Filed 2022-09-08 11:05 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+374,891 vol |
476,514 | |
Filed 2022-09-06 10:22 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-101,413.51
-15,389 vol $6.59 each |
194,443 | |
Filed 2022-09-06 10:21 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$198,266
+30,086 vol $6.59 each |
209,832 | |
Filed 2022-09-06 10:21 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-30,086 vol |
215,658 | |
Filed 2022-07-06 15:06 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,871
+822 vol $8.36 each |
134,563 | |
Filed 2022-07-06 15:04 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$36,065
+4,314 vol $8.36 each |
166,954 | |
Filed 2022-07-06 15:02 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$18,818
+2,251 vol $8.36 each |
123,267 | |
Filed 2022-07-06 15:00 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,622
+3,663 vol $8.36 each |
50,435 | |
Filed 2022-07-06 14:58 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,622
+3,663 vol $8.36 each |
50,413 | |
Filed 2022-07-06 14:42 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,367
+4,111 vol $8.36 each |
78,733 | |
Filed 2022-06-29 13:11 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
133,741 | |
Filed 2022-06-29 13:09 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
120,811 | |
Filed 2022-06-29 13:08 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
162,640 | |
Filed 2022-06-29 13:06 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Power, Robert Noel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
129,210 | |
Filed 2022-06-29 13:05 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
121,016 | |
Filed 2022-06-29 13:02 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
||
Filed 2022-06-29 12:59 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
36,704 | |
Filed 2022-06-29 12:58 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
46,772 | |
Filed 2022-06-29 12:56 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Kavanagh, Sarah Baldwin
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
117,447 | |
Filed 2022-06-29 12:53 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Karabelas, Argeris
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
119,715 | |
Filed 2022-06-29 12:52 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
46,750 | |
Filed 2022-06-29 12:49 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
74,622 | |
Filed 2022-06-23 11:55 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+16,898 vol |
16,898 | |
Filed 2022-06-23 11:54 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-06-03 15:00 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
$-38,835.06
-4,058 vol $9.57 each |
72,043 | |
Filed 2022-06-03 14:59 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$107,413
+11,224 vol $9.57 each |
76,101 | |
Filed 2022-06-03 14:58 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,224 vol |
49,496 | |
Filed 2022-05-17 19:00 Tx date 2022-05-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+2,317 vol |
2,317 | |
Filed 2022-05-17 18:52 Tx date 2022-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,753
+3,293 vol $10.25 each |
8,500 | |
Filed 2022-05-17 18:52 Tx date 2022-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,496
+1,707 vol $10.25 each |
5,207 | |
Filed 2022-05-16 17:04 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-316,911.60
-33,714 vol $9.40 each |
1,081,134 | |
Filed 2022-05-16 17:03 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$619,563
+65,911 vol $9.40 each |
1,114,848 | |
Filed 2022-05-16 17:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-65,911 vol |
983,705 | |
Filed 2022-05-16 17:00 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$619,563
+65,911 vol $9.40 each |
1,049,616 | |
Filed 2022-05-16 16:57 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$1,725,106
+183,522 vol $9.40 each |
983,705 | |
Filed 2022-05-16 16:56 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$1,096,951
+116,697 vol $9.40 each |
800,183 | |
Filed 2022-05-16 16:54 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$127,764
+13,592 vol $9.40 each |
74,983 | |
Filed 2022-05-16 16:53 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$81,244
+8,643 vol $9.40 each |
61,391 | |
Filed 2022-05-16 16:51 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$44,321
+4,715 vol $9.40 each |
7,467 | |
Filed 2022-05-16 16:50 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$25,868
+2,752 vol $9.40 each |
2,752 | |
Filed 2022-05-16 16:49 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-16 16:46 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$117,001
+12,447 vol $9.40 each |
134,217 | |
Filed 2022-05-16 16:45 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$184,005
+19,575 vol $9.40 each |
153,792 | |
Filed 2022-05-16 16:43 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$-117,001.80
-12,447 vol $9.40 each |
||
Filed 2022-05-13 19:05 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
183,581 | ||
Filed 2022-05-13 19:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
50,510 | ||
Filed 2022-05-13 19:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
18,060 | ||
Filed 2022-05-13 18:59 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-13 18:59 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-13 17:24 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Thomas George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
389,730 | ||
Filed 2022-05-13 17:20 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Thomas George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
101,623 | ||
Filed 2022-04-18 13:27 Tx date 2022-04-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,393.05
-1,595 vol $22.19 each |
24,617 | |
Filed 2022-04-05 12:06 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$38,113
+1,668 vol $22.85 each |
128,253 | |
Filed 2022-04-05 12:05 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
12,363 | |
Filed 2022-04-05 12:02 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,855
+300 vol $22.85 each |
99,354 | |
Filed 2022-04-05 11:59 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
12,385 | |
Filed 2022-04-05 11:57 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,366
+1,504 vol $22.85 each |
40,235 | |
Filed 2022-04-05 11:55 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
86,629 | |
Filed 2022-03-20 23:37 Tx date 2022-03-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-107,581.20
-4,846 vol $22.20 each |
26,212 | |
Filed 2022-03-11 16:15 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-18,927.84
-839 vol $22.56 each |
111,345 | |
Filed 2022-03-11 16:14 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,005
+1,463 vol $22.56 each |
112,184 | |
Filed 2022-03-11 16:13 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,463 vol |
50,895 | |
Filed 2022-03-10 16:27 Tx date 2022-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-84,624.64
-3,889 vol $21.76 each |
72,708 | |
Filed 2022-03-08 11:19 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-96,187.14
-4,074 vol $23.61 each |
31,058 | |
Filed 2022-03-08 11:18 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$188,006
+7,963 vol $23.61 each |
35,132 | |
Filed 2022-03-08 11:18 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,963 vol |
65,889 | |
Filed 2022-03-08 11:15 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,354.88
-608 vol $23.61 each |
10,958 | |
Filed 2022-03-08 11:14 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$41,860
+1,773 vol $23.61 each |
11,566 | |
Filed 2022-03-08 11:13 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,773 vol |
12,224 | |
Filed 2022-03-08 11:09 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-163,522.86
-6,926 vol $23.61 each |
110,721 | |
Filed 2022-03-08 11:09 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$285,279
+12,083 vol $23.61 each |
117,647 | |
Filed 2022-03-08 11:08 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-12,083 vol |
52,358 | |
Filed 2022-03-08 10:53 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-29,323.62
-1,242 vol $23.61 each |
64,877 | |
Filed 2022-03-08 10:53 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$81,029
+3,432 vol $23.61 each |
66,119 | |
Filed 2022-03-08 10:52 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,432 vol |
60,720 | |
Filed 2022-03-08 10:48 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-298,501.23
-12,643 vol $23.61 each |
1,048,937 | |
Filed 2022-03-08 10:48 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$583,544
+24,716 vol $23.61 each |
1,061,580 | |
Filed 2022-03-08 10:47 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-24,716 vol |
83,531 | |
Filed 2022-03-08 10:44 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-96,187.14
-4,074 vol $23.61 each |
76,597 | |
Filed 2022-03-08 10:42 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$188,006
+7,963 vol $23.61 each |
80,671 | |
Filed 2022-03-08 10:41 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,963 vol |
20,431 | |
Filed 2022-03-08 10:35 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-131,366.04
-5,564 vol $23.61 each |
179,746 | |
Filed 2022-03-08 10:33 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$256,758
+10,875 vol $23.61 each |
185,310 | |
Filed 2022-03-08 10:31 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,875 vol |
245,744 | |
Filed 2022-03-04 17:17 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-258,869.49
-11,077 vol $23.37 each |
72,708 | |
Filed 2022-03-04 17:12 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+565,330 vol |
852,455 | |
Filed 2022-03-04 17:11 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$3,690,517
+152,690 vol $24.17 each |
256,619 | |
Filed 2022-03-04 16:55 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+131,910 vol |
323,356 | |
Filed 2022-03-04 16:53 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$861,104
+35,627 vol $24.17 each |
73,852 | |
Filed 2022-03-04 16:52 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,275.15
-1,595 vol $23.37 each |
27,169 | |
Filed 2022-03-03 18:36 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-40,201.85
-1,651 vol $24.35 each |
28,764 | |
Filed 2022-03-03 18:35 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,641.80
-1,628 vol $24.35 each |
15,879 | |
Filed 2022-03-03 18:34 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-137,480.10
-5,646 vol $24.35 each |
30,415 | |
Filed 2022-03-03 18:33 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$111,206
+4,567 vol $24.35 each |
36,061 | |
Filed 2022-03-03 18:33 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$109,623
+4,502 vol $24.35 each |
17,507 | |
Filed 2022-03-03 18:32 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$380,225
+15,615 vol $24.35 each |
31,494 | |
Filed 2022-03-03 18:31 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,567 vol |
38,225 | |
Filed 2022-03-03 18:31 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,502 vol |
42,792 | |
Filed 2022-03-03 18:29 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-15,615 vol |
52,748 | |
Filed 2022-03-03 18:28 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+15,615 vol |
68,363 | |
Filed 2022-03-03 18:26 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-8,132.90
-334 vol $24.35 each |
9,793 | |
Filed 2022-03-03 18:26 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,451.10
-306 vol $24.35 each |
7,141 | |
Filed 2022-03-03 18:25 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,716
+974 vol $24.35 each |
10,127 | |
Filed 2022-03-03 18:24 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$21,695
+891 vol $24.35 each |
7,447 | |
Filed 2022-03-03 18:24 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-32,093.30
-1,318 vol $24.35 each |
9,153 | |
Filed 2022-03-03 18:23 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$81,085
+3,330 vol $24.35 each |
10,471 | |
Filed 2022-03-03 18:22 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-974 vol |
13,997 | |
Filed 2022-03-03 18:21 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-891 vol |
14,971 | |
Filed 2022-03-03 18:19 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-3,330 vol |
0 | |
Filed 2022-03-03 18:19 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+3,330 vol |
3,330 | |
Filed 2022-03-03 18:17 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-03 18:13 Tx date 2022-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-150,971.16
-6,338 vol $23.82 each |
83,785 | |
Filed 2022-03-03 18:12 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-41,784.60
-1,716 vol $24.35 each |
90,123 | |
Filed 2022-03-03 18:10 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,551
+5,074 vol $24.35 each |
91,839 | |
Filed 2022-03-03 18:09 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-37,060.70
-1,522 vol $24.35 each |
75,648 | |
Filed 2022-03-03 18:08 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$109,623
+4,502 vol $24.35 each |
77,170 | |
Filed 2022-03-03 18:01 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,074 vol |
28,394 | |
Filed 2022-03-03 18:00 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,502 vol |
33,468 | |
Filed 2022-03-03 17:58 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-151,773.55
-6,233 vol $24.35 each |
83,785 | |
Filed 2022-03-03 17:57 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$422,472
+17,350 vol $24.35 each |
90,018 | |
Filed 2022-03-03 17:56 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-17,350 vol |
16,073 | |
Filed 2022-03-03 17:56 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+17,350 vol |
33,423 | |
Filed 2022-03-03 17:53 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,775
+2,537 vol $24.35 each |
64,419 | |
Filed 2022-03-03 17:51 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-22,353.30
-918 vol $24.35 each |
62,687 | |
Filed 2022-03-03 17:50 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-19,820.90
-814 vol $24.35 each |
63,605 | |
Filed 2022-03-03 17:48 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-61,775.95
-2,537 vol $24.35 each |
||
Filed 2022-03-03 17:47 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$54,811
+2,251 vol $24.35 each |
56,310 | |
Filed 2022-03-03 17:46 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,537 vol |
64,152 | |
Filed 2022-03-03 17:45 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,251 vol |
66,689 | |
Filed 2022-03-03 17:43 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-75,533.70
-3,102 vol $24.35 each |
61,882 | |
Filed 2022-03-03 17:42 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$211,211
+8,674 vol $24.35 each |
64,984 | |
Filed 2022-03-03 17:40 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-8,674 vol |
6,412 | |
Filed 2022-03-03 17:39 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+8,674 vol |
15,086 | |
Filed 2022-03-03 17:35 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-58,488.70
-2,402 vol $24.35 each |
174,435 | |
Filed 2022-03-03 17:34 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-53,375.20
-2,192 vol $24.35 each |
154,223 | |
Filed 2022-03-03 17:33 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$172,982
+7,104 vol $24.35 each |
176,837 | |
Filed 2022-03-03 17:32 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$157,861
+6,483 vol $24.35 each |
156,415 | |
Filed 2022-03-03 17:30 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,104 vol |
103,929 | |
Filed 2022-03-03 17:29 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
111,033 | |
Filed 2022-03-03 17:26 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-213,841.70
-8,782 vol $24.35 each |
169,733 | |
Filed 2022-03-03 17:25 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$591,510
+24,292 vol $24.35 each |
178,515 | |
Filed 2022-03-03 17:24 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-24,292 vol |
121,770 | |
Filed 2022-03-03 17:23 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,292 vol |
146,062 | |
Filed 2022-03-03 17:18 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-73,196.10
-3,006 vol $24.35 each |
105,564 | |
Filed 2022-03-03 17:17 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-66,792.05
-2,743 vol $24.35 each |
108,570 | |
Filed 2022-03-03 17:16 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$172,982
+7,104 vol $24.35 each |
111,313 | |
Filed 2022-03-03 17:14 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$157,861
+6,483 vol $24.35 each |
90,196 | |
Filed 2022-03-03 17:12 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,104 vol |
64,441 | |
Filed 2022-03-03 17:11 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
71,545 | |
Filed 2022-03-03 16:55 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-250,293.65
-10,279 vol $24.35 each |
97,726 | |
Filed 2022-03-03 16:53 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$591,510
+24,292 vol $24.35 each |
108,005 | |
Filed 2022-03-03 16:52 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-24,292 vol |
49,613 | |
Filed 2022-03-03 16:50 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,292 vol |
73,905 | |
Filed 2022-03-03 15:35 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-321,566.10
-13,206 vol $24.35 each |
1,031,979 | |
Filed 2022-03-03 15:34 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$658,935
+27,061 vol $24.35 each |
1,045,185 | |
Filed 2022-03-03 15:33 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-321,006.05
-13,183 vol $24.35 each |
910,244 | |
Filed 2022-03-03 15:32 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$657,766
+27,013 vol $24.35 each |
923,427 | |
Filed 2022-03-03 15:30 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,061 vol |
118,247 | |
Filed 2022-03-03 15:29 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,013 vol |
145,308 | |
Filed 2022-03-03 15:15 Tx date 2022-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-123,066.90
-5,115 vol $24.06 each |
1,036,864 | |
Filed 2022-03-03 15:14 Tx date 2022-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$240,600
+10,000 vol $24.06 each |
1,041,979 | |
Filed 2022-03-03 15:13 Tx date 2022-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,000 vol |
108,247 | |
Filed 2022-03-03 15:06 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,443,546.85
-100,351 vol $24.35 each |
1,018,124 | |
Filed 2022-03-03 15:05 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,070,424
+208,231 vol $24.35 each |
1,118,475 | |
Filed 2022-03-03 15:03 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-208,231 vol |
683,486 | |
Filed 2022-03-03 15:02 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+208,231 vol |
891,717 | |
Filed 2022-02-17 17:15 Tx date 2022-02-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,340.02
-3,251 vol $25.02 each |
13,005 | |
Filed 2022-01-21 11:03 Tx date 2022-01-18 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,574.13
-3,251 vol $26.63 each |
16,256 | |
Filed 2022-01-04 13:03 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,245 vol |
38,731 | |
Filed 2022-01-04 13:00 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+249 vol |
99,054 | |
Filed 2022-01-04 12:57 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,380 vol |
126,585 | |
Filed 2022-01-04 12:55 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,109 vol |
85,289 | |
Filed 2022-01-04 12:53 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,109 vol |
11,045 | |
Filed 2022-01-04 12:50 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,109 vol |
11,023 | |
Filed 2021-12-16 18:19 Tx date 2021-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-84,759.89
-3,461 vol $24.49 each |
149,932 | |
Filed 2021-12-16 18:17 Tx date 2021-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$207,675
+8,480 vol $24.49 each |
153,393 | |
Filed 2021-12-16 18:16 Tx date 2021-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,480 vol |
117,516 | |
Filed 2021-11-30 16:36 Tx date 2021-11-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Holder: Individual Retirement Account (IRA) (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$241,698
+10,000 vol $24.17 each |
10,000 | |
Filed 2021-11-30 16:36 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Holder: Individual Retirement Account (IRA) (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-11-30 16:33 Tx date 2021-11-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,211,825
+50,000 vol $24.24 each |
50,844 | |
Filed 2021-11-30 16:31 Tx date 2021-11-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,211,825
+50,000 vol $24.24 each |
||
Filed 2021-11-05 18:02 Tx date 2021-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,953
+1,246 vol $27.25 each |
15,862 | |
Filed 2021-10-05 18:15 Tx date 2021-10-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-8,093.80
-283 vol $28.60 each |
19,507 | |
Filed 2021-10-05 18:14 Tx date 2021-10-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,023
+805 vol $28.60 each |
19,790 | |
Filed 2021-10-05 18:13 Tx date 2021-10-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-805 vol |
47,294 | |
Filed 2021-10-04 18:26 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,851
+246 vol $27.85 each |
98,805 | |
Filed 2021-10-04 18:24 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$38,098
+1,368 vol $27.85 each |
125,205 | |
Filed 2021-10-04 18:22 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,607
+1,099 vol $27.85 each |
84,180 | |
Filed 2021-10-04 18:20 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,607
+1,099 vol $27.85 each |
9,936 | |
Filed 2021-10-04 18:18 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,607
+1,099 vol $27.85 each |
9,914 | |
Filed 2021-10-04 18:16 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,366
+1,234 vol $27.85 each |
37,486 | |
Filed 2021-09-20 17:49 Tx date 2021-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-143,586.60
-5,010 vol $28.66 each |
896,414 | |
Filed 2021-09-20 17:48 Tx date 2021-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$286,600
+10,000 vol $28.66 each |
901,424 | |
Filed 2021-09-20 17:47 Tx date 2021-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,000 vol |
172,321 | |
Filed 2021-09-20 17:46 Tx date 2021-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-103,595.31
-3,549 vol $29.19 each |
891,424 | |
Filed 2021-09-20 17:44 Tx date 2021-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$206,752
+7,083 vol $29.19 each |
894,973 | |
Filed 2021-09-20 17:37 Tx date 2021-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,083 vol |
182,321 | |
Filed 2021-09-07 12:49 Tx date 2021-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+90,260 vol |
121,770 | |
Filed 2021-09-07 12:48 Tx date 2021-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+90,260 vol |
125,996 | |
Filed 2021-09-07 12:46 Tx date 2021-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+31,400 vol |
191,446 | |
Filed 2021-09-07 12:44 Tx date 2021-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+9,026 vol |
48,099 | |
Filed 2021-09-01 12:29 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,998.10
-1,278 vol $28.95 each |
18,985 | |
Filed 2021-09-01 12:28 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$108,012
+3,731 vol $28.95 each |
20,263 | |
Filed 2021-09-01 12:27 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,731 vol |
39,073 | |
Filed 2021-09-01 12:25 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-145,242.15
-5,017 vol $28.95 each |
83,713 | |
Filed 2021-09-01 12:23 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$271,840
+9,390 vol $28.95 each |
88,730 | |
Filed 2021-09-01 12:23 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-9,390 vol |
78,028 | |
Filed 2021-08-09 11:53 Tx date 2021-08-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,316
+1,400 vol $25.94 each |
3,500 | |
Filed 2021-08-06 16:54 Tx date 2021-08-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,123
+10,000 vol $25.01 each |
280,857 | |
Filed 2021-07-05 11:29 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,860
+234 vol $29.32 each |
98,559 | |
Filed 2021-07-05 11:27 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$38,116
+1,300 vol $29.32 each |
123,837 | |
Filed 2021-07-05 11:25 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,610
+1,044 vol $29.32 each |
83,081 | |
Filed 2021-07-05 11:22 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,610
+1,044 vol $29.32 each |
8,837 | |
Filed 2021-07-05 11:20 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,610
+1,044 vol $29.32 each |
8,815 | |
Filed 2021-07-05 11:17 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,363
+1,172 vol $29.32 each |
36,252 | |
Filed 2021-06-16 17:08 Tx date 2021-06-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-538,585.50
-17,000 vol $31.68 each |
54,059 | |
Filed 2021-06-08 15:09 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
46,672 | ||
Filed 2021-06-08 15:05 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
14,616 | ||
Filed 2021-06-08 15:01 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,556 | ||
Filed 2021-06-04 17:55 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-3,857,732.34
-121,198 vol $31.83 each |
79,340 | |
Filed 2021-06-04 17:54 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$932,267
+60,853 vol $15.32 each |
200,538 | |
Filed 2021-06-04 17:52 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$867,761
+60,345 vol $14.38 each |
139,685 | |
Filed 2021-06-04 17:51 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-60,853 vol |
235,738 | |
Filed 2021-06-04 17:48 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-60,345 vol |
296,591 | |
Filed 2021-06-04 17:35 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+122,427 vol |
252,506 | |
Filed 2021-06-04 17:33 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+33,673 vol |
68,940 | |
Filed 2021-05-28 16:54 Tx date 2021-05-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-350,811.045
-11,037 vol $31.79 each |
0 | |
Filed 2021-05-05 11:50 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+7,645 vol |
7,645 | |
Filed 2021-05-03 19:59 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
98,325 | |
Filed 2021-05-03 19:57 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
35,147 | |
Filed 2021-05-03 19:55 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
86,424 | |
Filed 2021-05-03 19:54 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
122,537 | |
Filed 2021-05-03 19:52 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Power, Robert Noel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
94,823 | |
Filed 2021-05-03 19:50 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
82,037 | |
Filed 2021-05-03 19:47 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
7,793 | |
Filed 2021-05-03 19:45 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Karabelas, Argeris
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
85,328 | |
Filed 2021-05-03 19:43 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Kavanagh, Sarah Baldwin
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
83,060 | |
Filed 2021-05-03 19:41 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
7,771 | |
Filed 2021-05-03 19:39 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
35,080 | |
Filed 2021-04-30 17:51 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$344,906
+11,037 vol $31.25 each |
11,037 | |
Filed 2021-04-30 17:49 Tx date 2016-06-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-04-30 17:49 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,037 vol |
90,680 | |
Filed 2021-04-30 17:47 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,250
+744 vol $31.25 each |
844 | |
Filed 2021-04-30 17:46 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-744 vol |
148 | |
Filed 2021-04-30 17:44 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,250
+744 vol $31.25 each |
744 | |
Filed 2021-04-30 17:44 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-744 vol |
126 | |
Filed 2021-04-30 17:41 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$344,906
+11,037 vol $31.25 each |
270,857 | |
Filed 2021-04-30 17:40 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,037 vol |
27,435 | |
Filed 2021-04-30 13:54 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$344,906
+11,037 vol $31.25 each |
11,037 | |
Filed 2021-04-30 13:53 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,037 vol |
0 | |
Filed 2021-04-05 13:13 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,855
+216 vol $31.74 each |
101,717 | |
Filed 2021-04-05 13:11 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$37,707
+1,188 vol $31.74 each |
114,892 | |
Filed 2021-04-05 13:09 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,216
+952 vol $31.74 each |
74,392 | |
Filed 2021-04-05 13:06 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$4,697
+148 vol $31.74 each |
892 | |
Filed 2021-04-05 13:04 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$3,999
+126 vol $31.74 each |
870 | |
Filed 2021-04-05 13:00 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,961
+1,070 vol $31.74 each |
38,472 | |
Filed 2021-03-24 18:02 Tx date 2021-03-22 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$24,552
+744 vol $33.00 each |
744 | |
Filed 2021-03-24 18:01 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-24 18:00 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100 | ||
Filed 2021-03-24 17:59 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-24 17:54 Tx date 2021-03-22 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$24,552
+744 vol $33.00 each |
744 | |
Filed 2021-03-24 17:50 Tx date 2021-03-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-15 17:16 Tx date 2021-03-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-26,124.72
-796 vol $32.82 each |
79,340 | |
Filed 2021-03-15 17:15 Tx date 2021-03-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,015
+1,463 vol $32.82 each |
80,136 | |
Filed 2021-03-15 17:14 Tx date 2021-03-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,463 vol |
87,418 | |
Filed 2021-03-11 18:40 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,622,268.36
-231,188 vol $32.97 each |
887,890 | |
Filed 2021-03-11 18:40 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,884 vol |
1,119,078 | |
Filed 2021-03-11 18:39 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+425,343 vol |
1,081,194 | |
Filed 2021-03-11 18:39 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-37,884 vol |
189,404 | |
Filed 2021-03-11 18:38 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-425,343 vol |
683,486 | |
Filed 2021-03-11 18:34 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-1,962,341.43
-59,519 vol $32.97 each |
256,853 | |
Filed 2021-03-11 18:33 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+19,889 vol |
316,372 | |
Filed 2021-03-11 18:32 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+99,842 vol |
296,483 | |
Filed 2021-03-11 18:32 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-19,889 vol |
129,765 | |
Filed 2021-03-11 18:30 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-99,842 vol |
76,276 | |
Filed 2021-03-11 18:26 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-410,839.17
-12,461 vol $32.97 each |
72,668 | |
Filed 2021-03-11 18:24 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,546 vol |
85,129 | |
Filed 2021-03-11 18:24 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+22,957 vol |
80,583 | |
Filed 2021-03-11 18:23 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,546 vol |
37,970 | |
Filed 2021-03-11 18:22 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-22,957 vol |
16,073 | |
Filed 2021-03-11 18:19 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-576,315.60
-17,480 vol $32.97 each |
144,913 | |
Filed 2021-03-11 18:18 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,388 vol |
162,393 | |
Filed 2021-03-11 18:18 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,305 vol |
155,005 | |
Filed 2021-03-11 18:16 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,388 vol |
35,736 | |
Filed 2021-03-11 18:15 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-37,305 vol |
31,510 | |
Filed 2021-03-11 18:12 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-242,692.17
-7,361 vol $32.97 each |
71,059 | |
Filed 2021-03-11 18:11 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,552 vol |
78,420 | |
Filed 2021-03-11 18:10 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+17,934 vol |
74,868 | |
Filed 2021-03-11 18:09 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,552 vol |
35,267 | |
Filed 2021-03-11 18:07 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-17,934 vol |
6,412 | |
Filed 2021-03-11 18:00 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-724,021.20
-21,960 vol $32.97 each |
78,673 | |
Filed 2021-03-11 17:58 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,819 vol |
100,633 | |
Filed 2021-03-11 17:57 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+34,435 vol |
93,814 | |
Filed 2021-03-11 17:56 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,819 vol |
88,881 | |
Filed 2021-03-11 17:54 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-34,435 vol |
49,613 | |
Filed 2021-03-05 19:09 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+16,476 vol |
39,030 | |
Filed 2021-03-05 19:07 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+16,476 vol |
52,748 | |
Filed 2021-03-05 19:06 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,749 vol |
160,046 | |
Filed 2021-03-05 19:05 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+23,892 vol |
42,804 | |
Filed 2021-03-05 19:04 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+354,275 vol |
1,108,829 | |
Filed 2021-03-05 19:02 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+196,464 vol |
1,794,471 | |
Filed 2021-03-05 19:01 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+74,150 vol |
227,288 | |
Filed 2021-03-05 18:59 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+46,138 vol |
176,118 | |
Filed 2021-03-05 18:58 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,684 vol |
1,552,360 | |
Filed 2021-03-05 18:57 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+63,439 vol |
149,654 | |
Filed 2021-03-05 18:55 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+46,138 vol |
68,692 | |
Filed 2021-03-05 18:55 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+46,138 vol |
||
Filed 2021-03-05 18:54 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,749 vol |
245,353 | |
Filed 2021-03-05 18:52 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+23,892 vol |
42,516 | |
Filed 2021-03-05 18:50 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+8,238 vol |
24,346 | |
Filed 2021-03-05 18:49 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+16,374 vol |
130,079 | |
Filed 2021-03-05 18:48 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+10,298 vol |
38,819 | |
Filed 2021-03-05 18:43 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+23,728 vol |
68,815 | |
Filed 2021-03-05 18:39 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+47,151 vol |
287,125 | |
Filed 2021-03-05 18:35 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+32,626 vol |
43,124 | |
Filed 2021-03-05 18:32 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+26,364 vol |
84,048 | |
Filed 2021-03-05 18:30 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+52,392 vol |
356,936 | |
Filed 2021-03-05 18:28 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+36,250 vol |
95,700 | |
Filed 2021-03-03 20:47 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-102,177.84
-3,252 vol $31.42 each |
16,532 | |
Filed 2021-03-03 20:46 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$284,916
+9,068 vol $31.42 each |
19,784 | |
Filed 2021-03-03 20:45 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-9,068 vol |
18,912 | |
Filed 2021-03-03 20:41 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-885,792.64
-28,192 vol $31.42 each |
655,851 | |
Filed 2021-03-03 20:40 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,013,205
+64,074 vol $31.42 each |
684,043 | |
Filed 2021-03-03 20:40 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-64,074 vol |
153,138 | |
Filed 2021-03-03 20:37 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-495,022.10
-15,755 vol $31.42 each |
196,641 | |
Filed 2021-03-03 20:36 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,319,074
+41,982 vol $31.42 each |
212,396 | |
Filed 2021-03-03 20:35 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-41,982 vol |
86,215 | |
Filed 2021-03-03 20:31 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-104,094.46
-3,313 vol $31.42 each |
57,626 | |
Filed 2021-03-03 20:30 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$300,877
+9,576 vol $31.42 each |
60,939 | |
Filed 2021-03-03 20:29 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-300,877.92
-9,576 vol $31.42 each |
||
Filed 2021-03-03 20:28 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-9,576 vol |
18,624 | |
Filed 2021-03-03 20:23 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-54,639.38
-1,739 vol $31.42 each |
52,146 | |
Filed 2021-03-03 20:23 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$150,438
+4,788 vol $31.42 each |
56,934 | |
Filed 2021-03-03 20:21 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,788 vol |
28,521 | |
Filed 2021-03-03 20:18 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-170,799.12
-5,436 vol $31.42 each |
117,700 | |
Filed 2021-03-03 20:17 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$426,872
+13,586 vol $31.42 each |
123,136 | |
Filed 2021-03-03 20:17 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,586 vol |
10,498 | |
Filed 2021-03-03 20:13 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-168,631.14
-5,367 vol $31.42 each |
59,379 | |
Filed 2021-03-03 20:12 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$426,872
+13,586 vol $31.42 each |
64,746 | |
Filed 2021-03-03 20:11 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,586 vol |
59,450 | |
Filed 2021-01-07 12:12 Tx date 2020-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,993
+1,442 vol $20.80 each |
73,440 | |
Filed 2021-01-07 12:10 Tx date 2020-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,737
+1,622 vol $20.80 each |
37,402 | |
Filed 2021-01-07 12:07 Tx date 2020-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,864
+330 vol $20.80 each |
101,501 | |
Filed 2021-01-07 12:04 Tx date 2020-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$37,481
+1,802 vol $20.80 each |
113,704 | |
Filed 2020-12-21 11:41 Tx date 2020-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-66,446.64
-3,224 vol $20.61 each |
109,550 | |
Filed 2020-12-21 11:40 Tx date 2020-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$174,772
+8,480 vol $20.61 each |
112,774 | |
Filed 2020-12-21 11:39 Tx date 2020-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-174,772.80
-8,480 vol $20.61 each |
24,084 | |
Filed 2020-12-14 15:02 Tx date 2020-12-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-2,266,398.3105
-114,055 vol $19.87 each |
190,867 | |
Filed 2020-12-14 14:59 Tx date 2020-12-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,640,110
+114,055 vol $14.38 each |
304,922 | |
Filed 2020-12-14 14:58 Tx date 2020-12-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,640,110.90
-114,055 vol $14.38 each |
101,148 | |
Filed 2020-12-01 16:09 Tx date 2020-11-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-268,207.4226
-13,663 vol $19.63 each |
190,867 | |
Filed 2020-12-01 16:08 Tx date 2020-11-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$196,473
+13,663 vol $14.38 each |
204,530 | |
Filed 2020-12-01 16:07 Tx date 2020-11-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-196,473.94
-13,663 vol $14.38 each |
215,203 | |
Filed 2020-12-01 16:06 Tx date 2020-11-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-425,196.3534
-21,658 vol $19.63 each |
190,867 | |
Filed 2020-12-01 16:05 Tx date 2020-11-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$311,442
+21,658 vol $14.38 each |
212,525 | |
Filed 2020-12-01 16:04 Tx date 2020-11-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-311,442.04
-21,658 vol $14.38 each |
228,866 | |
Filed 2020-12-01 16:02 Tx date 2020-11-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-29,115.4424
-1,483 vol $19.63 each |
190,867 | |
Filed 2020-12-01 16:01 Tx date 2020-11-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,678
+1,438 vol $14.38 each |
192,350 | |
Filed 2020-12-01 16:00 Tx date 2020-11-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-21,325.54
-1,483 vol $14.38 each |
250,524 | |
Filed 2020-10-26 13:51 Tx date 2020-10-21 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-10,009 vol |
0 | |
Filed 2020-10-06 17:25 Tx date 2020-10-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,385.64
-276 vol $15.89 each |
10,716 | |
Filed 2020-10-06 17:24 Tx date 2020-10-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,775
+804 vol $15.89 each |
10,992 | |
Filed 2020-10-06 17:23 Tx date 2020-10-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-804 vol |
27,980 | |
Filed 2020-10-05 13:05 Tx date 2020-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,737
+2,171 vol $15.54 each |
35,780 | |
Filed 2020-10-05 13:03 Tx date 2020-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,992
+1,930 vol $15.54 each |
71,998 | |
Filed 2020-10-05 13:01 Tx date 2020-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$37,498
+2,413 vol $15.54 each |
111,902 | |
Filed 2020-10-05 12:58 Tx date 2020-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,868
+442 vol $15.54 each |
101,171 | |
Filed 2020-09-16 19:13 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-26,124.22
-1,642 vol $15.91 each |
170,414 | |
Filed 2020-09-16 19:12 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$53,028
+3,333 vol $15.91 each |
172,056 | |
Filed 2020-09-16 19:12 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,333 vol |
128,197 | |
Filed 2020-09-16 19:08 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-81,379.65
-5,115 vol $15.91 each |
619,969 | |
Filed 2020-09-16 19:08 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$159,100
+10,000 vol $15.91 each |
625,084 | |
Filed 2020-09-16 19:06 Tx date 2020-09-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,000 vol |
217,212 | |
Filed 2020-09-16 19:04 Tx date 2020-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-55,794.20
-3,623 vol $15.40 each |
615,084 | |
Filed 2020-09-16 19:03 Tx date 2020-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$109,062
+7,082 vol $15.40 each |
618,707 | |
Filed 2020-09-16 19:02 Tx date 2020-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,082 vol |
227,212 | |
Filed 2020-09-14 11:21 Tx date 2020-09-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,635.39
-5,667 vol $16.17 each |
190,912 | |
Filed 2020-09-01 16:56 Tx date 2020-08-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-21,726
-1,278 vol $17.00 each |
10,188 | |
Filed 2020-09-01 16:55 Tx date 2020-08-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$63,410
+3,730 vol $17.00 each |
11,466 | |
Filed 2020-09-01 16:54 Tx date 2020-08-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,730 vol |
28,784 | |
Filed 2020-09-01 16:47 Tx date 2020-08-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+28,171 vol |
73,036 | |
Filed 2020-08-20 16:57 Tx date 2020-08-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-79,831.16
-4,567 vol $17.48 each |
196,579 | |
Filed 2020-08-20 16:55 Tx date 2020-08-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$178,890
+10,234 vol $17.48 each |
201,146 | |
Filed 2020-08-20 16:55 Tx date 2020-08-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,234 vol |
44,123 | |
Filed 2020-07-03 11:43 Tx date 2020-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$32,007
+1,750 vol $18.29 each |
33,609 | |
Filed 2020-07-03 11:41 Tx date 2020-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,858
+375 vol $18.29 each |
100,729 | |
Filed 2020-07-03 11:39 Tx date 2020-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$37,494
+2,050 vol $18.29 each |
109,489 | |
Filed 2020-07-03 11:37 Tx date 2020-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,258
+1,545 vol $18.29 each |
70,068 | |
Filed 2020-06-02 19:53 Tx date 2020-05-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
127,297 | ||
Filed 2020-06-02 19:51 Tx date 2020-05-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
36,272 | ||
Filed 2020-06-02 19:50 Tx date 2020-05-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
32,514 | ||
Filed 2020-06-02 19:49 Tx date 2020-05-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,736 | ||
Filed 2020-05-15 18:18 Tx date 2020-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,314,792
+585,100 vol $15.92 each |
12,215,361 | |
Filed 2020-05-15 18:18 Tx date 2020-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,917,163
+624,900 vol $15.87 each |
11,630,261 | |
Filed 2020-05-15 18:17 Tx date 2020-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,095,500
+70,000 vol $15.65 each |
11,005,361 | |
Filed 2020-05-15 18:16 Tx date 2020-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,530,382
+348,920 vol $15.85 each |
10,935,361 | |
Filed 2020-05-15 18:15 Tx date 2020-05-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,785,594
+645,844 vol $16.70 each |
10,586,441 | |
Filed 2020-05-15 18:14 Tx date 2020-05-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,331,373
+80,300 vol $16.58 each |
9,940,597 | |
Filed 2020-05-15 18:14 Tx date 2020-05-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,855,648
+603,900 vol $16.32 each |
9,860,297 | |
Filed 2020-05-15 18:13 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,495,907
+374,836 vol $17.33 each |
9,256,397 | |
Filed 2020-05-15 18:12 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,850,750
+162,900 vol $17.50 each |
8,881,561 | |
Filed 2020-05-15 18:12 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,790,275
+799,900 vol $17.24 each |
8,718,661 | |
Filed 2020-05-15 18:11 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$432,500
+25,000 vol $17.30 each |
7,918,761 | |
Filed 2020-05-15 18:10 Tx date 2020-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Partners LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,851,648
+678,400 vol $17.47 each |
7,893,761 | |
Filed 2020-05-06 18:45 Tx date 2020-05-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-1,638,591.24
-95,489 vol $17.16 each |
611,625 | |
Filed 2020-05-06 18:44 Tx date 2020-05-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,203,480
+186,683 vol $17.16 each |
707,114 | |
Filed 2020-05-06 18:43 Tx date 2020-05-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-186,683 vol |
234,294 | |
Filed 2020-05-04 12:07 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
11,037 | |
Filed 2020-05-04 12:05 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$181,262
+10,009 vol $18.11 each |
10,009 | |
Filed 2020-05-04 12:03 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,633 vol |
0 | |
Filed 2020-05-04 11:10 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
27,502 | |
Filed 2020-05-04 11:09 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
100,354 | |
Filed 2020-05-04 11:07 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
78,779 | |
Filed 2020-05-04 11:05 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
107,439 | |
Filed 2020-05-04 11:04 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Power, Robert Noel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
87,178 | |
Filed 2020-05-04 11:01 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
68,523 | |
Filed 2020-05-04 10:58 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Kavanagh, Sarah Baldwin
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
75,415 | |
Filed 2020-05-04 10:55 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Karabelas, Argeris
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
77,683 | |
Filed 2020-05-04 10:46 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
31,859 | |
Filed 2020-05-04 10:43 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-11,300.64
-624 vol $18.11 each |
259,820 | |
Filed 2020-05-04 10:43 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$192,563
+10,633 vol $18.11 each |
260,444 | |
Filed 2020-05-04 10:42 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,633 vol |
20,822 | |
Filed 2020-04-02 17:53 Tx date 2020-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,248
+2,016 vol $15.50 each |
31,455 | |
Filed 2020-04-02 17:51 Tx date 2020-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,497
+1,774 vol $15.50 each |
57,486 | |
Filed 2020-04-02 17:50 Tx date 2020-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$37,494
+2,419 vol $15.50 each |
96,402 | |
Filed 2020-04-02 17:47 Tx date 2020-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,866
+443 vol $15.50 each |
89,317 | |
Filed 2020-03-16 16:42 Tx date 2020-03-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,837
+2,500 vol $15.54 each |
11,500 | |
Filed 2020-03-12 10:34 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-387,508.48
-18,488 vol $20.96 each |
520,431 | |
Filed 2020-03-12 10:34 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$794,048
+37,884 vol $20.96 each |
538,919 | |
Filed 2020-03-12 10:33 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-794,048.64
-37,884 vol $20.96 each |
420,977 | |
Filed 2020-03-12 10:30 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-195,514.88
-9,328 vol $20.96 each |
168,723 | |
Filed 2020-03-12 10:30 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$416,873
+19,889 vol $20.96 each |
178,051 | |
Filed 2020-03-12 10:26 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-416,873.44
-19,889 vol $20.96 each |
131,530 | |
Filed 2020-03-12 10:24 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-46,929.44
-2,239 vol $20.96 each |
51,363 | |
Filed 2020-03-12 10:24 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$95,284
+4,546 vol $20.96 each |
53,602 | |
Filed 2020-03-12 10:23 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-95,284.16
-4,546 vol $20.96 each |
28,200 | |
Filed 2020-03-12 10:21 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,659.04
-1,749 vol $20.96 each |
53,885 | |
Filed 2020-03-12 10:21 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$74,428
+3,551 vol $20.96 each |
55,634 | |
Filed 2020-03-12 10:20 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-74,428.96
-3,551 vol $20.96 each |
33,309 | |
Filed 2020-03-12 10:19 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-57,304.64
-2,734 vol $20.96 each |
104,294 | |
Filed 2020-03-12 10:18 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$154,831
+7,387 vol $20.96 each |
107,028 | |
Filed 2020-03-12 10:17 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-154,831.52
-7,387 vol $20.96 each |
32,564 | |
Filed 2020-03-12 10:15 Tx date 2020-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+4,390 vol |
44,865 | |
Filed 2020-03-12 10:14 Tx date 2020-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80,105
+4,390 vol $18.25 each |
51,160 | |
Filed 2020-03-12 10:12 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-70,069.28
-3,343 vol $20.96 each |
46,770 | |
Filed 2020-03-12 10:12 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$142,926
+6,819 vol $20.96 each |
50,113 | |
Filed 2020-03-12 10:11 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-142,926.24
-6,819 vol $20.96 each |
40,475 | |
Filed 2020-03-12 10:07 Tx date 2020-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,996
+1,100 vol $18.18 each |
2,100 | |
Filed 2020-03-12 09:44 Tx date 2020-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$69,377
+3,800 vol $18.26 each |
13,800 | |
Filed 2020-03-12 09:44 Tx date 2017-01-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
Filed 2020-03-12 09:42 Tx date 2020-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$115,414
+5,000 vol $23.08 each |
249,811 | |
Filed 2020-03-11 17:29 Tx date 2020-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-110,911
-4,925 vol $22.52 each |
501,035 | |
Filed 2020-03-11 17:29 Tx date 2020-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$225,200
+10,000 vol $22.52 each |
505,960 | |
Filed 2020-03-11 17:28 Tx date 2020-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-225,200
-10,000 vol $22.52 each |
458,861 | |
Filed 2020-03-11 17:26 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-226,534.36
-9,269 vol $24.44 each |
495,960 | |
Filed 2020-03-11 17:26 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$661,346
+27,060 vol $24.44 each |
505,229 | |
Filed 2020-03-11 17:25 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-661,346.40
-27,060 vol $24.44 each |
468,861 | |
Filed 2020-03-11 17:21 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-55,332.16
-2,264 vol $24.44 each |
190,912 | |
Filed 2020-03-11 17:21 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,984
+5,073 vol $24.44 each |
193,176 | |
Filed 2020-03-11 17:20 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-123,984.12
-5,073 vol $24.44 each |
54,357 | |
Filed 2020-03-11 17:18 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-175,161.48
-7,167 vol $24.44 each |
158,162 | |
Filed 2020-03-11 17:17 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$512,531
+20,971 vol $24.44 each |
165,329 | |
Filed 2020-03-11 17:17 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-512,531.24
-20,971 vol $24.44 each |
151,419 | |
Filed 2020-03-11 17:13 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-61,075.56
-2,499 vol $24.44 each |
49,056 | |
Filed 2020-03-11 17:12 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,984
+5,073 vol $24.44 each |
51,555 | |
Filed 2020-03-11 17:11 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-123,984.12
-5,073 vol $24.44 each |
32,746 | |
Filed 2020-03-11 17:09 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-21,238.36
-869 vol $24.44 each |
52,083 | |
Filed 2020-03-11 17:08 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,979
+2,536 vol $24.44 each |
52,952 | |
Filed 2020-03-11 17:07 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-61,979.84
-2,536 vol $24.44 each |
36,860 | |
Filed 2020-03-11 17:06 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-68,334.24
-2,796 vol $24.44 each |
99,641 | |
Filed 2020-03-11 17:05 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$173,597
+7,103 vol $24.44 each |
102,437 | |
Filed 2020-03-11 17:04 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-173,597.32
-7,103 vol $24.44 each |
39,951 | |
Filed 2020-03-11 17:02 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-92,358.76
-3,779 vol $24.44 each |
43,294 | |
Filed 2020-03-11 17:01 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$173,597
+7,103 vol $24.44 each |
47,073 | |
Filed 2020-03-11 17:00 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-173,597.32
-7,103 vol $24.44 each |
47,294 | |
Filed 2020-03-11 16:52 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+121,560 vol |
754,554 | |
Filed 2020-03-11 16:51 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+121,560 vol |
632,994 | |
Filed 2020-03-11 16:50 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+341,114 vol |
1,598,007 | |
Filed 2020-03-11 16:49 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+81,040 vol |
495,921 | |
Filed 2020-03-11 16:47 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,004 vol |
22,554 | |
Filed 2020-03-11 16:46 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,004 vol |
13,550 | |
Filed 2020-03-11 16:46 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+56,858 vol |
212,604 | |
Filed 2020-03-11 16:44 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,506 vol |
37,819 | |
Filed 2020-03-11 16:43 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,004 vol |
18,008 | |
Filed 2020-03-11 16:42 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,004 vol |
9,004 | |
Filed 2020-03-11 16:41 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+56,858 vol |
252,007 | |
Filed 2020-03-11 16:40 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,506 vol |
59,430 | |
Filed 2020-03-11 16:38 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+25,212 vol |
129,980 | |
Filed 2020-03-11 16:38 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+25,212 vol |
104,768 | |
Filed 2020-03-11 16:37 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+159,192 vol |
1,460,676 | |
Filed 2020-03-11 16:35 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+63,030 vol |
172,390 | |
Filed 2020-03-11 16:28 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+4,502 vol |
16,108 | |
Filed 2020-03-11 16:28 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+4,502 vol |
11,606 | |
Filed 2020-03-11 16:27 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,429 vol |
113,705 | |
Filed 2020-03-11 16:26 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+6,753 vol |
39,396 | |
Filed 2020-03-11 16:23 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+12,966 vol |
45,087 | |
Filed 2020-03-11 16:22 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+12,966 vol |
32,121 | |
Filed 2020-03-11 16:21 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+81,873 vol |
239,974 | |
Filed 2020-03-11 16:20 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+19,449 vol |
47,054 | |
Filed 2020-03-11 16:16 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+12,966 vol |
57,684 | |
Filed 2020-03-11 16:15 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+12,966 vol |
44,718 | |
Filed 2020-03-11 16:13 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+81,873 vol |
304,544 | |
Filed 2020-03-11 16:11 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+19,449 vol |
54,397 | |
Filed 2020-02-28 17:32 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-592,121.88
-22,378 vol $26.46 each |
39,970 | |
Filed 2020-02-28 17:31 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,118,384
+42,267 vol $26.46 each |
62,348 | |
Filed 2020-02-28 17:30 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$208,081
+7,864 vol $26.46 each |
20,081 | |
Filed 2020-02-28 17:29 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-16,384 vol |
31,752 | |
Filed 2020-02-28 17:27 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-261,054.36
-9,866 vol $26.46 each |
95,334 | |
Filed 2020-02-28 17:26 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$559,179
+21,133 vol $26.46 each |
105,200 | |
Filed 2020-02-28 17:26 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$103,883
+3,932 vol $26.42 each |
84,067 | |
Filed 2020-02-28 17:25 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-8,192 vol |
19,155 | |
Filed 2020-02-28 17:22 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-236,631.78
-8,943 vol $26.46 each |
50,416 | |
Filed 2020-02-28 17:21 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$236,631
+8,943 vol $26.46 each |
||
Filed 2020-02-28 17:20 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$582,490
+22,014 vol $26.46 each |
59,359 | |
Filed 2020-02-28 17:19 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$108,380
+4,096 vol $26.46 each |
37,345 | |
Filed 2020-02-28 17:18 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-8,534 vol |
7,104 | |
Filed 2020-02-28 17:12 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-309,193.26
-11,703 vol $26.42 each |
46,482 | |
Filed 2020-02-28 17:11 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$744,462
+28,178 vol $26.42 each |
58,185 | |
Filed 2020-02-28 17:10 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$138,703
+5,242 vol $26.46 each |
30,007 | |
Filed 2020-02-28 17:09 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-5,461 vol |
4,546 | |
Filed 2020-02-28 17:04 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-41,002 vol |
0 | |
Filed 2020-02-28 16:51 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$553,305
+20,911 vol $26.46 each |
138,852 | |
Filed 2020-02-28 16:51 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,799,018
+105,783 vol $26.46 each |
244,635 | |
Filed 2020-02-28 16:50 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-20,911 vol |
||
Filed 2020-02-28 16:50 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-20,911 vol |
20,091 | |
Filed 2020-02-28 16:48 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-1,495,836.72
-56,532 vol $26.46 each |
188,103 | |
Filed 2020-02-28 16:47 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-105,783 vol |
||
Filed 2020-02-28 16:46 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,799,018
+105,783 vol $26.46 each |
||
Filed 2020-02-28 16:43 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$553,305
+20,911 vol $26.46 each |
||
Filed 2020-02-28 16:41 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-105,783 vol |
||
Filed 2020-02-28 16:36 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-20,911 vol |
||
Filed 2020-02-28 16:36 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-20,911 vol |
||
Filed 2020-01-10 12:39 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-62,311.56
-2,118 vol $29.42 each |
24,765 | |
Filed 2020-01-10 12:39 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$160,662
+5,461 vol $29.42 each |
26,883 | |
Filed 2020-01-10 12:38 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-160,662.62
-5,461 vol $29.42 each |
24,313 | |
Filed 2020-01-10 12:26 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-125,535.14
-4,267 vol $29.42 each |
32,643 | |
Filed 2020-01-10 12:25 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$125,535
+4,267 vol $29.42 each |
34,943 | |
Filed 2020-01-10 12:23 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-49,837.48
-1,694 vol $29.42 each |
33,249 | |
Filed 2020-01-10 12:22 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$125,535
+4,267 vol $29.42 each |
||
Filed 2020-01-10 12:21 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-125,535.14
-4,267 vol $29.42 each |
||
Filed 2020-01-10 12:20 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-53,750.34
-1,827 vol $29.42 each |
80,135 | |
Filed 2020-01-10 12:19 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$120,504
+4,096 vol $29.42 each |
81,962 | |
Filed 2020-01-10 12:18 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-120,504.32
-4,096 vol $29.42 each |
27,605 | |
Filed 2020-01-10 12:16 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-98,851.20
-3,360 vol $29.42 each |
12,217 | |
Filed 2020-01-10 12:15 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$241,008
+8,192 vol $29.42 each |
15,577 | |
Filed 2020-01-10 12:14 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-241,008.64
-8,192 vol $29.42 each |
34,948 | |
Filed 2020-01-07 18:31 Tx date 2020-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-435,605.28
-14,559 vol $29.92 each |
117,941 | |
Filed 2020-01-07 18:30 Tx date 2020-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,294,937
+43,280 vol $29.92 each |
132,500 | |
Filed 2020-01-07 18:29 Tx date 2020-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-43,280 vol |
45,924 | |
Filed 2020-01-03 12:22 Tx date 2019-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,236
+1,044 vol $29.92 each |
29,439 | |
Filed 2020-01-03 12:20 Tx date 2019-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,496
+919 vol $29.92 each |
55,712 | |
Filed 2020-01-03 12:17 Tx date 2019-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$37,489
+1,253 vol $29.92 each |
93,983 | |
Filed 2020-01-03 12:15 Tx date 2019-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,864
+1,065 vol $29.92 each |
88,874 | |
Filed 2019-12-18 12:16 Tx date 2019-12-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-103,447
-3,337 vol $31.00 each |
77,866 | |
Filed 2019-12-18 12:15 Tx date 2019-12-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$262,880
+8,480 vol $31.00 each |
81,203 | |
Filed 2019-12-18 12:14 Tx date 2019-12-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,480 vol |
31,701 | |
Filed 2019-10-04 17:26 Tx date 2019-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,857
+1,458 vol $21.85 each |
87,809 | |
Filed 2019-10-04 17:24 Tx date 2019-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,245
+1,430 vol $21.85 each |
28,395 | |
Filed 2019-10-04 17:21 Tx date 2019-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$37,494
+1,716 vol $21.85 each |
92,730 | |
Filed 2019-10-04 17:18 Tx date 2019-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,487
+1,258 vol $21.85 each |
54,793 | |
Filed 2019-09-23 10:44 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-38,160.08
-1,642 vol $23.24 each |
144,358 | |
Filed 2019-09-23 10:43 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$77,458
+3,333 vol $23.24 each |
146,000 | |
Filed 2019-09-23 10:42 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,333 vol |
109,360 | |
Filed 2019-09-23 10:40 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-118,872.60
-5,115 vol $23.24 each |
478,169 | |
Filed 2019-09-23 10:39 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$232,399
+10,000 vol $23.24 each |
483,284 | |
Filed 2019-09-23 10:39 Tx date 2019-09-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,000 vol |
414,881 | |
Filed 2019-09-16 18:48 Tx date 2019-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+21,248 vol |
424,881 | |
Filed 2019-09-16 18:46 Tx date 2019-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$699,300
+30,000 vol $23.31 each |
473,284 | |
Filed 2019-08-27 17:59 Tx date 2019-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-551,600
-24,625 vol $22.40 each |
142,667 | |
Filed 2019-08-27 17:58 Tx date 2019-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,120,000
+50,000 vol $22.40 each |
167,292 | |
Filed 2019-08-27 17:57 Tx date 2019-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,000 vol |
112,693 | |
Filed 2019-08-26 18:34 Tx date 2019-08-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-178,110.60
-8,362 vol $21.30 each |
72,723 | |
Filed 2019-08-26 18:34 Tx date 2019-08-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$452,582
+21,248 vol $21.30 each |
81,085 | |
Filed 2019-08-26 18:33 Tx date 2019-08-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-21,248 vol |
40,181 | |
Filed 2019-08-26 18:29 Tx date 2019-08-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+30,703 vol |
89,204 | |
Filed 2019-08-26 18:26 Tx date 2019-08-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650,142
+30,703 vol $21.18 each |
89,220 | |
Filed 2019-08-26 18:22 Tx date 2019-08-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-76,725.555
-3,418 vol $22.45 each |
7,385 | |
Filed 2019-08-26 18:18 Tx date 2019-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-174,171.81
-7,779 vol $22.39 each |
10,803 | |
Filed 2019-08-26 18:17 Tx date 2019-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$327,229
+14,615 vol $22.39 each |
18,582 | |
Filed 2019-08-26 18:16 Tx date 2019-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-14,615 vol |
43,140 | |
Filed 2019-07-23 19:53 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-25,287.50
-1,190 vol $21.25 each |
2,020 | |
Filed 2019-07-23 19:53 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$63,452
+2,986 vol $21.25 each |
3,210 | |
Filed 2019-07-23 19:52 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,986 vol |
17,921 | |
Filed 2019-07-23 19:50 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-46,091.25
-2,169 vol $21.25 each |
17,105 | |
Filed 2019-07-23 19:50 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$116,046
+5,461 vol $21.25 each |
19,274 | |
Filed 2019-07-23 19:49 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,461 vol |
21,120 | |
Filed 2019-07-23 19:47 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,040
-1,696 vol $21.25 each |
16,781 | |
Filed 2019-07-23 19:46 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$90,652
+4,266 vol $21.25 each |
18,477 | |
Filed 2019-07-23 19:45 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,266 vol |
50,782 | |
Filed 2019-07-23 19:43 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,592.50
-1,722 vol $21.25 each |
55,357 | |
Filed 2019-07-23 19:42 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$87,040
+4,096 vol $21.25 each |
57,079 | |
Filed 2019-07-23 19:41 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,096 vol |
47,506 | |
Filed 2019-07-23 19:39 Tx date 2019-07-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-98,446.08
-3,968 vol $24.81 each |
3,967 | |
Filed 2019-07-23 19:36 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-73,227.50
-3,446 vol $21.25 each |
4,746 | |
Filed 2019-07-23 19:33 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$174,080
+8,192 vol $21.25 each |
8,192 | |
Filed 2019-07-23 19:32 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,192 vol |
43,264 | |
Filed 2019-07-05 16:16 Tx date 2019-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,852
+1,263 vol $25.22 each |
86,351 | |
Filed 2019-07-05 16:14 Tx date 2019-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$37,476
+1,486 vol $25.22 each |
91,014 | |
Filed 2019-07-05 16:12 Tx date 2019-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,489
+1,090 vol $25.22 each |
53,535 | |
Filed 2019-07-05 16:09 Tx date 2019-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,247
+1,239 vol $25.22 each |
26,965 | |
Filed 2019-06-26 17:24 Tx date 2019-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-45,567.66
-1,913 vol $23.82 each |
5,843 | |
Filed 2019-06-26 17:23 Tx date 2019-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$100,877
+4,235 vol $23.82 each |
7,756 | |
Filed 2019-06-26 17:22 Tx date 2019-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,235 vol |
26,876 | |
Filed 2019-06-07 12:54 Tx date 2019-06-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-132,050.10
-6,370 vol $20.73 each |
28,106 | |
Filed 2019-06-07 12:52 Tx date 2019-06-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$371,709
+17,931 vol $20.73 each |
34,476 | |
Filed 2019-06-07 12:51 Tx date 2019-06-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-17,931 vol |
41,176 | |
Filed 2019-05-10 18:06 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-16,292.43
-693 vol $23.51 each |
18,130 | |
Filed 2019-05-10 18:05 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$47,513
+2,021 vol $23.51 each |
18,823 | |
Filed 2019-05-10 18:05 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,021 vol |
35,235 | |
Filed 2019-05-10 18:02 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-17,538.46
-746 vol $23.51 each |
3,521 | |
Filed 2019-05-10 18:01 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$51,157
+2,176 vol $23.51 each |
4,267 | |
Filed 2019-05-10 18:00 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,176 vol |
31,111 | |
Filed 2019-05-10 17:10 Tx date 2019-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-9,885 vol |
0 | |
Filed 2019-05-06 15:48 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+10,633 vol |
10,633 | |
Filed 2019-05-06 15:46 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$233,582
+9,885 vol $23.63 each |
9,885 | |
Filed 2019-05-06 15:43 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,881 vol |
0 | |
Filed 2019-05-06 15:41 Tx date 2017-09-21 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Hale, David Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-12,803 vol |
0 | |
Filed 2019-05-06 11:57 Tx date 2018-10-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+5,832 vol |
5,832 | |
Filed 2019-05-06 11:48 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
16,465 | |
Filed 2019-05-06 11:47 Tx date 2018-10-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-06 11:45 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
85,088 | |
Filed 2019-05-06 11:44 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
67,742 | |
Filed 2019-05-06 11:41 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
89,528 | |
Filed 2019-05-06 11:40 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Power, Robert Noel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
76,141 | |
Filed 2019-05-06 11:38 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
52,445 | |
Filed 2019-05-06 11:36 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Kavanagh, Sarah Baldwin
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
64,378 | |
Filed 2019-05-06 11:33 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Karabelas, Argeris
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
66,646 | |
Filed 2019-05-06 11:30 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-94,425.48
-3,996 vol $23.63 each |
244,811 | |
Filed 2019-05-06 11:28 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$328,008
+13,881 vol $23.63 each |
248,807 | |
Filed 2019-05-06 11:28 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,881 vol |
15,093 | |
Filed 2019-05-06 11:26 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
25,726 | |
Filed 2019-04-12 10:24 Tx date 2019-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,113 vol |
41,812 | |
Filed 2019-04-12 10:22 Tx date 2019-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,265 vol |
28,974 | |
Filed 2019-04-12 10:18 Tx date 2019-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,290 vol |
74,455 | |
Filed 2019-04-12 10:15 Tx date 2019-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,518 vol |
78,895 | |
Filed 2019-03-18 Tx date 2019-03-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$10,159,040 vol $97.00 each |
$3,694,000 | |
Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$4,618,000 vol $97.13 each |
||
Filed 2019-03-18 Tx date 2019-03-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$3,694,000 vol $96.75 each |
$0 | |
Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$382,000 vol $97.13 each |
$1,146,960 | |
Filed 2019-03-18 Tx date 2019-03-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$764,000 vol $96.50 each |
$2,292,960 | |
Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$4,618,000 vol $97.13 each |
||
Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$764,000 vol $96.88 each |
$1,528,960 | |
Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$9,236,000 vol $96.88 each |
$18,471,040 | |
Filed 2019-03-18 Tx date 2019-03-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$840,960 vol $97.00 each |
$306,000 | |
Filed 2019-03-18 Tx date 2019-03-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$306,000 vol $96.75 each |
$0 | |
Filed 2019-03-18 Tx date 2019-03-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$9,236,000 vol $96.50 each |
$27,707,040 | |
Filed 2019-03-18 Tx date 2019-03-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$4,618,000 vol $97.13 each |
$13,853,040 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-22,947.44
-974 vol $23.56 each |
2,091 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$160,655
+6,819 vol $23.56 each |
6,819 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-230,793.76
-9,796 vol $23.56 each |
117,292 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-160,655.64
-6,819 vol $23.56 each |
65,947 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-66,933.96
-2,841 vol $23.56 each |
33,287 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-85,522.80
-3,630 vol $23.56 each |
3,189 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-68,488.92
-2,907 vol $23.56 each |
57,463 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$439,582
+18,658 vol $23.56 each |
443,284 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$83,661
+3,551 vol $23.56 each |
17,762 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$66,933
+2,841 vol $23.56 each |
3,065 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-174,037.72
-7,387 vol $23.56 each |
65,525 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$468,584
+19,889 vol $23.56 each |
127,088 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-28,672.52
-1,217 vol $23.56 each |
16,545 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-107,103.76
-4,546 vol $23.56 each |
37,256 | |
Filed 2019-03-13 Tx date 2018-10-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000 | ||
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-83,661.56
-3,551 vol $23.56 each |
59,107 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-468,584.84
-19,889 vol $23.56 each |
162,693 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$107,103
+4,546 vol $23.56 each |
18,359 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,682.92
-1,557 vol $23.56 each |
16,802 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-892,547.04
-37,884 vol $23.56 each |
403,633 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$892,547
+37,884 vol $23.56 each |
424,626 | |
Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$174,037
+7,387 vol $23.56 each |
60,370 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+44,290 vol |
195,149 | |
Filed 2019-03-12 Tx date 2019-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$710,100
+30,000 vol $23.67 each |
386,742 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+236,183 vol |
1,256,893 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+15,221 vol |
58,501 | |
Filed 2019-03-12 Tx date 2019-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+30,000 vol |
441,517 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+62,915 vol |
182,582 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+44,290 vol |
114,816 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+21,310 vol |
72,912 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+81,182 vol |
411,517 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+21,310 vol |
72,766 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+7,610 vol |
62,658 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+62,004 vol |
158,101 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+62,004 vol |
222,671 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+15,221 vol |
36,128 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,149 vol |
85,276 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+44,290 vol |
155,746 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+124,002 vol |
1,301,484 | |
Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+15,221 vol |
41,802 | |
Filed 2019-03-11 Tx date 2019-03-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$1,826,000 vol $95.50 each |
||
Filed 2019-03-11 Tx date 2019-03-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$22,718,000 vol $96.00 each |
$55,117,040 | |
Filed 2019-03-11 Tx date 2019-03-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$4,544,000 vol $96.13 each |
$77,835,040 | |
Filed 2019-03-11 Tx date 2017-06-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-03-11 Tx date 2019-03-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$456,000 vol $96.13 each |
$7,164,960 | |
Filed 2019-03-11 Tx date 2019-03-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$1,826,000 vol $95.50 each |
||
Filed 2019-03-11 Tx date 2019-03-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$18,174,000 vol $95.50 each |
$36,943,040 | |
Filed 2019-03-11 Tx date 2019-03-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$1,826,000 vol $95.50 each |
$3,056,960 | |
Filed 2019-03-11 Tx date 2018-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
90 - Change in the nature of ownership
|
-$7,620,960 vol |
$82,379,040 | |
Filed 2019-03-11 Tx date 2019-03-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
10 - Acquisition or disposition in the public market
|
$
-$2,282,000 vol $96.00 each |
$4,882,960 | |
Filed 2019-03-11 Tx date 2018-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Holder: Paulson Credit Opportunities Master II Ltd. (Indirect Ownership)
|
Bonds Corporate Bond 6.125% 04/15/2025
90 - Change in the nature of ownership
|
+$7,620,960 vol |
$7,620,960 | |
Filed 2019-01-07 Tx date 2018-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$27,483
+1,488 vol $18.47 each |
40,699 | |
Filed 2019-01-07 Tx date 2019-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-245,854.17
-13,311 vol $18.47 each |
58,517 | |
Filed 2019-01-07 Tx date 2019-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-43,280 vol |
43,280 | |
Filed 2019-01-07 Tx date 2018-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,232
+1,691 vol $18.47 each |
27,709 | |
Filed 2019-01-07 Tx date 2018-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,694
+1,716 vol $18.47 each |
73,165 | |
Filed 2019-01-07 Tx date 2018-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$40,818
+2,210 vol $18.47 each |
77,377 | |
Filed 2019-01-07 Tx date 2019-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Humphries, William Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$799,381
+43,280 vol $18.47 each |
71,828 | |
Filed 2018-10-18 Tx date 2018-10-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-382,481.32
-15,404 vol $24.83 each |
4,542 | |
Filed 2018-10-18 Tx date 2018-10-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-115,821
-4,542 vol $25.50 each |
0 | |
Filed 2018-10-03 Tx date 2018-09-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,071 vol |
39,211 | |
Filed 2018-10-03 Tx date 2018-09-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,217 vol |
26,018 | |
Filed 2018-10-03 Tx date 2018-09-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,217 vol |
71,449 | |
Filed 2018-10-03 Tx date 2018-09-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,460 vol |
75,167 | |
Filed 2018-09-18 Tx date 2018-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,995,000
+125,000 vol $23.96 each |
234,926 | |
Filed 2018-09-18 Tx date 2018-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$226,100
+10,000 vol $22.61 each |
107,199 | |
Filed 2018-09-18 Tx date 2018-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+10,000 vol |
119,667 | |
Filed 2018-09-18 Tx date 2018-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$669,600
+30,000 vol $22.32 each |
356,742 | |
Filed 2018-09-18 Tx date 2018-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+30,000 vol |
330,335 | |
Filed 2018-08-27 Tx date 2018-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,000 vol |
109,667 | |
Filed 2018-08-27 Tx date 2018-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,118,500
+50,000 vol $22.37 each |
121,825 | |
Filed 2018-08-27 Tx date 2018-08-23 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Herendeen, Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-550,883.62
-24,626 vol $22.37 each |
97,199 | |
Filed 2018-08-26 Tx date 2018-08-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$460,847
+21,247 vol $21.69 each |
58,484 | |
Filed 2018-08-26 Tx date 2018-08-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-21,247 vol |
51,602 | |
Filed 2018-08-26 Tx date 2018-08-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-119,316.69
-5,501 vol $21.69 each |
52,983 | |
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,813 | ||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
10,007 | ||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
26,581 | ||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
111,456 | ||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
20,907 | ||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
224 | ||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
6,541 | ||
Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
70,526 | ||
Filed 2018-08-15 Tx date 2018-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$343,744
+14,615 vol $23.52 each |
27,725 | |
Filed 2018-08-15 Tx date 2018-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-14,615 vol |
51,456 | |
Filed 2018-08-15 Tx date 2018-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-182,962.08
-7,779 vol $23.52 each |
19,946 |